Imperial Brands reaffirms FY26 targets despite Mid-East second-half risk

Imperial Brands reiterated FY26 guidance, targeting at least high-single-digit EPS growth, at least 5% adjusted operating profit growth, and free cash flow of at least £2.2 billion. First-half tobacco and next-generation revenue is expected to grow in low-single digits, with next-generation product revenue up mid-to-high single digits, but management flagged uncertainty from the Middle East conflict and a 2-2.5% FX headwind. The company has completed £700 million of its £1.45 billion buyback and expects leverage to stay at the low end of its 2-2.5x net debt range.

Analysis

The market is likely underestimating how much of Imperial’s equity story is now a financial engineering vehicle rather than a pure operating turnaround. With leverage pinned near the bottom of target and buybacks already executed at pace, incremental cash flow is being forced into per-share accretion, which makes modest operating misses less important unless they are large enough to threaten the repurchase cadence. That creates a near-term floor for the stock, but it also means the multiple is increasingly hostage to capital allocation discipline and FX rather than volume growth.

The more interesting second-order effect is in the next-generation mix. Premiumization in Europe can mask share loss in legacy cigarettes, but the U.S. promotional intensity is a warning that this category is not yet behaving like a structurally high-margin engine across geographies. If promotions stay elevated for another 1-2 quarters, the market may start discounting the growth rate of the next-gen segment more aggressively than headline revenue implies, especially because investors typically pay for durability, not just share gains.

Geopolitics is the main tail risk, but the impact is asymmetric: the first-order risk is not demand destruction, it is logistics, insurance, and input-cost volatility that can hit operating margin before consumer demand visibly rolls over. The bigger issue is timing — any Middle East escalation that persists into the second half would land when buyback support is already partially used up, leaving less equity support exactly as translation FX and litigation cash outflows continue to drain headline EPS. That combination can compress the stock’s “defensive” premium very quickly.

Consensus is probably too complacent on the sustainability of capital returns. A £2.2bn FCF guide sounds robust, but once you net the settlement payments, FX drag, and buybacks, the margin for operational disappointment is not that wide. The contrarian view is that Imperial may be a better cash distribution story than a growth story, which argues for owning it only while the buyback remains aggressive and the multiple stays below where peers trade on earnings quality.

Key Decisions for Investors

• Long IMB on a 1-3 month horizon, but only on pullbacks; target is continued per-share accretion from buybacks, with a tight stop if second-half guidance is cut or buyback pace slows.
• Buy IMB Jan-2027 put spreads as a hedge against Middle East escalation and FX pressure; risk/reward improves if the stock re-rates on buyback support but operating visibility deteriorates into H2.
• Pair trade: long IMB / short BT.A over the next 1-2 quarters if you want a cleaner capital-return and leverage story; IMB has more visible buyback support and better downside protection from its lower leverage band.
• If the stock rallies on the guidance reiteration, trim strength rather than chase; the setup is tactical, not secular, and the next catalyst is H1 results, where promo intensity and FX could reset expectations.
• For event-driven accounts, watch for any signs of an accelerated buyback cadence or special return; that would be the highest-conviction add signal because it would tighten the per-share math without requiring operating upside.